Uniplan Investment Counsel’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.96M Buy
193,905
+25,995
+15% +$1.05M 0.84% 32
2026
Q1
$5.56M Sell
167,910
-10,666
-6% -$347K 0.57% 47
2025
Q4
$5.84M Buy
178,576
+19,838
+12% +$488K 0.59% 46
2025
Q3
$2.83M Sell
158,738
-26,231
-14% -$381K 0.28% 92
2025
Q2
$2.01M Buy
184,969
+49,490
+37% +$648K 0.2% 106
2025
Q1
$2.51M Buy
+135,479
New +$2.44M 0.24% 96

Other funds holding AXGN

Uniplan Investment Counsel's AXGN Position: Q2 2026 in Review

Uniplan Investment Counsel increased its Axogen (AXGN) stake by 15% in Q2 2026, buying an estimated $1.05M and bringing the position to 193,905 shares worth $8.96M. The position accounts for 0.84% of the portfolio, ranked #32.

Uniplan Investment Counsel first reported a position in AXGN in Q1 2025 and has held it in 6 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Uniplan Investment Counsel held 193,905 shares of Axogen worth $8.96M as of Q2 2026.
  • Uniplan Investment Counsel bought 25,995 Axogen shares in Q2 2026, an estimated $1.05M.
  • Axogen made up 0.84% of Uniplan Investment Counsel's portfolio in Q2 2026, its #32 holding.
  • Uniplan Investment Counsel first reported a position in Axogen in Q1 2025 and has held it in 6 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.